前瞻性头对头比较[68Ga]Ga-PSMA-11 PET/MR与PET/CT在生化复发前列腺癌中的应用
PET/MR与PET/CT对局部复发、淋巴结转移和远处转移的检出准确性至少相当,联合解读时PET/MR检出病灶数更多(88 vs 81)。
要点
- PET/MR对生化复发灶的检出效能不劣于PET/CT,联合MRI可增加病灶检出数。
- PET/MR上局部复发和淋巴结转移的SUVmean及SUVmax显著高于PET/CT。
- 单独CT或MRI的病灶检出数显著低于PET/CT或PET/MR。
关键影像表现/征象
- PET/CT与PET/MR分别有19例和20例阳性,分别检出73个和79个病灶,PET/CT所检病灶均被PET/MR检出。
- 单独CT和单独MRI分别有14例和17例阳性,分别检出38个和50个病灶,显著低于PET/CT和PET/MR。
- 联合解读时PET/MR较PET/CT检出更多病灶(88 vs 81)。
- 局部复发和淋巴结转移的SUVmean和SUVmax在PET/MR上显著高于PET/CT。
临床应用与阅片要点
- 对于生化复发前列腺癌,PET/MR可替代PET/CT进行定位,利用MRI优势提高病灶检出。
- 联合MRI解读可增加病灶检出数,但需注意单独CT或MRI检出率显著低于PET融合图像。
局限性
- 单中心前瞻性设计,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: PSMA-PET has become the PET technique of choice to localise the site of biochemically recurrent prostate cancer (PCa). With hybrid PET/MRI, the advantages of MRI are added to molecular characteristic of PET. The aim of this study was to investigate the incremental value of PET/MR versus PET/CT in patients with biochemically recurrent PCa by head-to-head comparison.
METHODS: Thirty-four patients with biochemically recurrent PCa were prospectively included. They underwent [68Ga]Ga-PSMA-11 PET/CT, followed by simultaneous PET/MR. All PET (PETCT, PETMR), CT and MR images were evaluated for number of lesions and location. The number of lesions at specific sites was compared using Wilcoxon-sign-rank test. For PET, the maximum and mean standardised uptake values (SUVs) were calculated for each lesion compared using a two-sided paired t test.
RESULTS: PETCT and PETMR scans were positive in 19 and 20 patients, detecting 73 and 79 lesions respectively. All lesions detected on PETCT were also detected on PETMR. CT and MRI only were positive in 14 and 17 patients, detecting 38 and 50 lesions, respectively, which was significantly lower than PETCT and PETMR respectively. Combined interpretation showed more lesions on PET/MR than on PET/CT (88 vs 81). No significant difference in detection of presence of local recurrence nor distant metastases was found. SUVmean and SUVmax values were significantly higher on PETMR than on PETCT in local recurrence and lymph node metastases.
CONCLUSIONS: [68Ga]Ga-PSMA-11 PET/MR was able to detect biochemically recurrent PCa at least as accurately as PET/CT for local recurrence, lymph node metastasis and distant metastasis.
KEY POINTS: • PSMA PET/MRI detects the location of biochemical recurrence at least as accurately as PET/CT. • Substitution of PET/CT by PET/MRI adds sensitivity in PSMA lesion detection also in the setting of distant recurrence due to both the MR and TOF PET components.
引用
- Jentjens S, Mai C, Ahmadi Bidakhvidi N, et al. Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer. Eur Radiol. 2021. PMID: 34374802. doi:10.1007/s00330-021-08140-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。